Jiao-En Wu

43PUBLICATIONS
52CO-AUTHORS
Cancer geneticsMolecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Feb 10, 2026
Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876.

Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang

|Jan 10, 2026
First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy.

Yan-Jei Tang, Rung-Hsuan Chen, Yung-Shin Lu

|Nov 22, 2025
PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.

Chiao-Ping Chen, Tsai-Hsien Hung, Yenlin Huang

|Nov 20, 2025
Clinicopathological Features and Immunochemical Staining of Inflammatory Myofibroblastic Tumor: A Retrospective Study of 48 Cases.

Qi-An Wang, Ren-Chin Wu, Chao-Wei Lee

|Oct 27, 2025
Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Wei-Ming Huang, Chen-Han Chueh, Chien-Yu Tseng

|Jul 08, 2025
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study.

I-Lin Tsai, Chien-Yu Lin, Po-Lan Su

Pageof 8

Frequent Collaborators

6 joint publications

Yi-Ru Pan

5 joint publications

Jen-Shi Chen

5 joint publications

Wen-Kuan Huang

5 joint publications

Chun-Nan Yeh